title: Cardiac remodeling and dysfunction in nephrotic syndrome.
abstract: There is an increased incidence of heart disease in patients with chronic nephrotic syndrome (NS), which may be attributable to the malnutrition and activated inflammatory state accompanying the sustained proteinuria. In this study, we evaluated renal function, cardiac morphometry, contractile function, and myocardial gene expression in the established puromycin aminonucleoside nephrosis rat model of NS. Two weeks after aminonucleoside injection, there was massive proteinuria, decreased creatinine clearance, and a negative sodium balance. Skeletal and cardiac muscle atrophy was present and was accompanied by impaired left ventricular (LV) hemodynamic function along with decreased contractile properties of isolated LV muscle strips. The expression of selected cytokines and proteins involved in calcium handling in myocardial tissue was evaluated by real time polymerase chain reaction. This revealed that the expression of interleukin-1beta, tumor necrosis factor-alpha, and phospholamban were elevated, whereas that of cardiac sarco(endo)plasmic reticulum calcium pump protein was decreased. We suggest that protein wasting and systemic inflammatory activation during NS contribute to cardiac remodeling and dysfunction.
authors: Unit of Research and Development of Nephrology, University of Porto, Porto, Portugal.
authors: M
authors: M
authors: Moreira-Rodrigues
authors: R
authors: R
authors: Roncon-Albuquerque
authors: T
authors: T
authors: Henriques-Coelho
authors: A P
authors: AP
authors: Lourenço
authors: B
authors: B
authors: Sampaio-Maia
authors: J
authors: J
authors: Santos
authors: M
authors: M
authors: Pestana
authors: A F
authors: AF
authors: Leite-Moreira
mesh_terms: D000818:Animals; D001794:Blood Pressure; D002135:Calcium-Binding Proteins / Q000235:genetics; D015536:Down-Regulation; D015870:Gene Expression; D006352:Heart Ventricles / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology; D053583:Interleukin-1beta / Q000235:genetics; D008297:Male; D009119:Muscle Contraction; D018482:Muscle, Skeletal / Q000473:pathology; D009133:Muscular Atrophy / Q000209:etiology* / Q000473:pathology*; D009206:Myocardium / Q000378:metabolism / Q000473:pathology*; D009404:Nephrotic Syndrome / Q000139:chemically induced / Q000150:complications*; D011692:Puromycin Aminonucleoside / Q000633:toxicity; D051381:Rats; D017207:Rats, Sprague-Dawley; D053498:Sarcoplasmic Reticulum Calcium-Transporting ATPases / Q000235:genetics; D012964:Sodium / Q000378:metabolism; D013318:Stroke Volume; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics; D015854:Up-Regulation; D014882:Water-Electrolyte Balance; D000099211:Phospholamban
chemical_list: D002135:Calcium-Binding Proteins; D053583:Interleukin-1beta; D011692:Puromycin Aminonucleoside; D053498:Sarcoplasmic Reticulum Calcium-Transporting ATPases; D012964:Sodium; D014409:Tumor Necrosis Factor-alpha; D000099211:Phospholamban